Benefits of giving Pfizer jab to 5-11-year-olds ‘outweigh risks’

Benefits of giving the Pfizer/BioNTech COVID vaccine to 5 to 11-year-olds clearly outweigh the risks, according to a US drug watchdog.

The assessment by scientists at the country’s Food and Drug Administration (FDA) comes as the makers of the vaccine said it showed 90.7% efficacy against coronavirus in a clinical trial of children in that age group.

Mark Gibson

Graduates in Northwestern University, Evanston, Illinois 1990. Move to Los Angeles California in 2004. Specialized in Internet journalism.

Leave a Reply

Your email address will not be published. Required fields are marked *